Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Dewailly

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Endocrinology|February 9, 2002
MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomasGustavo Soto-Ares, Christine Cortet-Rudelli, Richard Assaker, et al.
Neuroimage|December 9, 2009
Sex steroid hormones-related structural plasticity in the human hypothalamusMarc Baroncini, Patrice Jissendi, Sophie Catteau-Jonard, et al.
Fertility and Sterility|September 5, 2024
Pulsatile gonadotropin-releasing hormone therapy: comparison of efficacy between functional hypothalamic amenorrhea and congenital hypogonadotropic hypogonadismHortense Everaere, Virginie Simon, Anne Bachelot, et al.
Fertility and Sterility|February 1, 2002
Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndromeChristine Cortet-Rudelli, Pascal Pigny, Christine Decanter, et al.
Journal of Clinical Medicine|August 12, 2023
How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?Lucie Huyghe, Camille Robin, Agathe Dumont, et al.
Human Reproduction (Oxford, England)|July 21, 2023
Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysisMaeliss Peigné, Valérie Bernard, Laura Dijols, et al.
Reproductive Biomedicine Online|October 13, 2020
The proportion of cleaved anti-Müllerian hormone is higher in serum but not follicular fluid of obese women independently of polycystic ovary syndromeMaëliss Peigné, Pascal Pigny, Michaël W Pankhurst, et al.
Reproductive Biology and Endocrinology : RB&E|January 6, 2022
Polycystic ovary syndrome phenotype does not have impact on oocyte morphologyAudrey Uk, Christine Decanter, Camille Grysole, et al.
Fertility and Sterility|December 3, 2014
Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative studyJulien Sigala, Christophe Sifer, Didier Dewailly, et al.
Human Reproduction Update|June 6, 2017
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult womenEnrico Carmina, Didier Dewailly, Héctor F Escobar-Morreale, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Endocrinology|February 9, 2002
MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomasGustavo Soto-Ares, Christine Cortet-Rudelli, Richard Assaker, et al.
Neuroimage|December 9, 2009
Sex steroid hormones-related structural plasticity in the human hypothalamusMarc Baroncini, Patrice Jissendi, Sophie Catteau-Jonard, et al.
Fertility and Sterility|September 5, 2024
Pulsatile gonadotropin-releasing hormone therapy: comparison of efficacy between functional hypothalamic amenorrhea and congenital hypogonadotropic hypogonadismHortense Everaere, Virginie Simon, Anne Bachelot, et al.
Fertility and Sterility|February 1, 2002
Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndromeChristine Cortet-Rudelli, Pascal Pigny, Christine Decanter, et al.
Journal of Clinical Medicine|August 12, 2023
How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?Lucie Huyghe, Camille Robin, Agathe Dumont, et al.
Human Reproduction (Oxford, England)|July 21, 2023
Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysisMaeliss Peigné, Valérie Bernard, Laura Dijols, et al.
Reproductive Biomedicine Online|October 13, 2020
The proportion of cleaved anti-Müllerian hormone is higher in serum but not follicular fluid of obese women independently of polycystic ovary syndromeMaëliss Peigné, Pascal Pigny, Michaël W Pankhurst, et al.
Reproductive Biology and Endocrinology : RB&E|January 6, 2022
Polycystic ovary syndrome phenotype does not have impact on oocyte morphologyAudrey Uk, Christine Decanter, Camille Grysole, et al.
Fertility and Sterility|December 3, 2014
Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative studyJulien Sigala, Christophe Sifer, Didier Dewailly, et al.
Human Reproduction Update|June 6, 2017
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult womenEnrico Carmina, Didier Dewailly, Héctor F Escobar-Morreale, et al.
Pageof 13